The medicinal chemistry of androgens provides a classic illustration of how modifying a core chemical structure can lead to profound changes in pharmacokinetic properties and therapeutic use. Understanding the relationship between the steroid nucleus, its functional groups, and its pharmacological activity is a key concept rooted in principles from Medicinal Chemistry I and applied in the Patient Care 5 curriculum. This quiz will test your knowledge on the structure-activity relationships, prodrug strategies, and chemical principles governing androgen and anti-androgen therapies.
1. Androgens like testosterone are classified as steroid hormones because they all share a core structure known as the:
- a. Phenothiazine nucleus
- b. Benzodiazepine ring
- c. Cyclopentanoperhydrophenanthrene nucleus
- d. Purine ring
Answer: c. Cyclopentanoperhydrophenanthrene nucleus
2. The conversion of testosterone to the more potent androgen, dihydrotestosterone (DHT), is what type of chemical reaction?
- a. Oxidation
- b. Reduction of a double bond
- c. Esterification
- d. Aromatization
Answer: b. Reduction of a double bond
3. Which functional group on the testosterone molecule is essential for its binding to the androgen receptor?
- a. The C3-keto group
- b. The C17-hydroxyl group
- c. The C4-C5 double bond
- d. All of the above are important for binding and activity.
Answer: d. All of the above are important for binding and activity.
4. Why is oral administration of native testosterone ineffective?
- a. It is not absorbed from the gut.
- b. It undergoes extensive first-pass metabolism in the liver.
- c. It is too acidic and damages the stomach.
- d. It is too large to be absorbed.
Answer: b. It undergoes extensive first-pass metabolism in the liver.
5. Testosterone cypionate and testosterone enanthate are administered via intramuscular injection. They are examples of what type of chemical modification?
- a. A soft drug
- b. A salt formulation
- c. A prodrug created by esterification
- d. A chiral inversion
Answer: c. A prodrug created by esterification
6. The purpose of adding a long-chain ester to the C17-hydroxyl group of testosterone is to:
- a. Increase its water solubility.
- b. Make the molecule more potent at the receptor.
- c. Increase its lipophilicity, allowing it to be slowly released from an oily depot.
- d. Allow for intravenous administration.
Answer: c. Increase its lipophilicity, allowing it to be slowly released from an oily depot.
7. Finasteride treats benign prostatic hyperplasia (BPH) by inhibiting which enzyme?
- a. Aromatase
- b. 5-alpha reductase
- c. CYP3A4
- d. Xanthine oxidase
Answer: b. 5-alpha reductase
8. From a medicinal chemistry perspective, finasteride is designed to act as a(n):
- a. Competitive agonist at the androgen receptor.
- b. Allosteric modulator of the androgen receptor.
- c. Mechanism-based inhibitor of the 5-alpha reductase enzyme.
- d. Prodrug of testosterone.
Answer: c. Mechanism-based inhibitor of the 5-alpha reductase enzyme.
9. Bicalutamide is a non-steroidal anti-androgen used for prostate cancer. What is its mechanism of action?
- a. It inhibits 5-alpha reductase.
- b. It inhibits the release of GnRH.
- c. It competitively antagonizes the androgen receptor.
- d. It inhibits testosterone synthesis.
Answer: c. It competitively antagonizes the androgen receptor.
10. The aromatase enzyme is responsible for converting testosterone into what other hormone?
- a. Dihydrotestosterone (DHT)
- b. Progesterone
- c. Estradiol
- d. Aldosterone
Answer: c. Estradiol
11. The management of men’s health disorders is a topic within the Patient Care 5 curriculum.
- a. True
- b. False
Answer: a. True
12. The historical practice of adding a methyl group to the C17-alpha position of testosterone (e.g., methyltestosterone) allowed for oral activity but significantly increased the risk of:
- a. Nephrotoxicity
- b. Cardiotoxicity
- c. Hepatotoxicity
- d. Neurotoxicity
Answer: c. Hepatotoxicity
13. Predicting the effects of functional groups on drug properties is a key objective of which foundational course?
- a. PHA5439 Principles of Medicinal Chemistry and Pharmacology I
- b. PHA5161L Professional Practice Skills Lab I
- c. PHA5007 Population Health
- d. PHA5103 Principles of Patient-Centered Care
Answer: a. PHA5439 Principles of Medicinal Chemistry and Pharmacology I
14. Anabolic steroids are synthetic derivatives of testosterone often designed to maximize the anabolic (muscle-building) effects relative to the androgenic (masculinizing) effects. This is an example of modifying:
- a. The drug’s formulation.
- b. The drug’s structure-activity relationship (SAR).
- c. The drug’s route of administration.
- d. The drug’s half-life only.
Answer: b. The drug’s structure-activity relationship (SAR).
15. The “-steride” suffix in finasteride and dutasteride indicates that these drugs are:
- a. Androgen receptor blockers
- b. 5-alpha reductase inhibitors
- c. Steroidal hormones
- d. Aromatase inhibitors
Answer: b. 5-alpha reductase inhibitors
16. The “Hormonal Agents” lecture in the oncology module covers anti-androgens.
- a. True
- b. False
Answer: a. True
17. What structural feature of testosterone allows it to be a substrate for the aromatase enzyme?
- a. The C17-hydroxyl group.
- b. The C19-methyl group.
- c. The A-ring, which can be converted to an aromatic (phenolic) ring.
- d. The ester linkage.
Answer: c. The A-ring, which can be converted to an aromatic (phenolic) ring.
18. Dutasteride differs from finasteride in that it:
- a. Is more selective for the type 2 isoenzyme of 5-alpha reductase.
- b. Is a non-competitive inhibitor.
- c. Inhibits both type 1 and type 2 isoenzymes of 5-alpha reductase.
- d. Is less potent.
Answer: c. Inhibits both type 1 and type 2 isoenzymes of 5-alpha reductase.
19. From a medicinal chemistry perspective, testosterone is considered a(n):
- a. Prodrug
- b. Active hormone
- c. Antagonist
- d. Peptide
Answer: b. Active hormone
20. An active learning session on urological disorders, where these agents are used, is part of the Patient Care 5 course.
- a. True
- b. False
Answer: a. True
21. The “pharmacophore” for androgen receptor binding requires which key features on the steroid nucleus?
- a. An ionized carboxyl group.
- b. A 3-keto group and a 17-beta-hydroxyl group.
- c. A large peptide chain.
- d. A furan ring.
Answer: b. A 3-keto group and a 17-beta-hydroxyl group.
22. Which of the following is NOT a steroid?
- a. Testosterone
- b. Estradiol
- c. Cortisol
- d. Liraglutide
Answer: d. Liraglutide
23. The principles of drug biotransformation are covered in the Medicinal Chemistry curriculum.
- a. True
- b. False
Answer: a. True
24. An active learning session on men’s health is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
25. Non-steroidal anti-androgens like bicalutamide were designed to:
- a. Have the same structure as testosterone.
- b. Mimic the shape of testosterone to bind to the androgen receptor without having a steroid structure.
- c. Inhibit testosterone synthesis.
- d. Be more potent than DHT.
Answer: b. Mimic the shape of testosterone to bind to the androgen receptor without having a steroid structure.
26. The lipophilicity of testosterone is the reason it is formulated in what for IM injections?
- a. An aqueous solution
- b. A saline solution
- c. An oily vehicle (e.g., sesame oil, cottonseed oil)
- d. An alcohol-based solution
Answer: c. An oily vehicle (e.g., sesame oil, cottonseed oil)
27. The term structure-activity relationship (SAR) refers to how:
- a. The structure of a drug influences its activity.
- b. The cost of a drug relates to its activity.
- c. The name of a drug relates to its activity.
- d. The dosage form relates to its activity.
Answer: a. The structure of a drug influences its activity.
28. An active learning session on urological disorders is part of which course module?
- a. Module 8: Urological Disorders
- b. Module 1: Diabetes Mellitus
- c. Module 3: Women’s Health
- d. Module 6: Geriatrics
Answer: a. Module 8: Urological Disorders
29. The androgen receptor is what type of receptor?
- a. A cell surface G-protein coupled receptor.
- b. A ligand-gated ion channel.
- c. An intracellular nuclear hormone receptor.
- d. A receptor tyrosine kinase.
Answer: c. An intracellular nuclear hormone receptor.
30. The “Management of Testosterone Deficiency” is a lecture within the Patient Care 5 curriculum.
- a. True
- b. False
Answer: a. True
31. The removal of the C19-methyl group from testosterone (to form 19-nortestosterone derivatives like nandrolone) generally results in:
- a. A decrease in all activity.
- b. An increase in the anabolic-to-androgenic activity ratio.
- c. An increase in androgenic activity only.
- d. A complete loss of function.
Answer: b. An increase in the anabolic-to-androgenic activity ratio.
32. From a chemical perspective, testosterone is a(n) ________ hormone.
- a. hydrophilic
- b. lipophilic
- c. amphipathic
- d. charged
Answer: b. lipophilic
33. Predicting how functional groups interact with receptors is a key objective in which course?
- a. PHA5439 Principles of Medicinal Chemistry and Pharmacology I
- b. PHA5161L Professional Practice Skills Lab I
- c. PHA5007 Population Health
- d. PHA5103 Principles of Patient-Centered Care
Answer: a. PHA5439 Principles of Medicinal Chemistry and Pharmacology I
34. The “trans” fusion of the rings in the steroid nucleus gives the molecule what overall shape?
- a. A flexible, linear shape.
- b. A bent, L-shape.
- c. A rigid, planar-like shape.
- d. A spherical shape.
Answer: c. A rigid, planar-like shape.
35. A pharmacist’s understanding of medicinal chemistry helps them to:
- a. Predict potential drug interactions based on structure.
- b. Explain the mechanism of action of a drug.
- c. Understand why different formulations exist.
- d. All of the above.
Answer: d. All of the above.
36. The nitroaromatic group in flutamide (an older anti-androgen) is a key part of its:
- a. Efficacy
- b. Antagonist properties
- c. Potential for hepatotoxicity
- d. Water solubility
Answer: c. Potential for hepatotoxicity
37. The chemical difference between testosterone and estradiol is primarily:
- a. The number of carbon atoms.
- b. The A-ring of estradiol is aromatic (a phenol), while testosterone’s is not.
- c. The type of functional group at C17.
- d. Estradiol is much larger.
Answer: b. The A-ring of estradiol is aromatic (a phenol), while testosterone’s is not.
38. The lecture “Management of BPH” is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
39. A patient is using a transdermal testosterone patch. The drug delivery system must be designed to allow the lipophilic drug to partition out of the patch and into the:
- a. Intramuscular tissue
- b. Stratum corneum of the skin
- c. Bloodstream directly
- d. Stomach
Answer: b. Stratum corneum of the skin
40. An active learning session covering men’s health is part of which course?
- a. PHA5787C Patient Care 5
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5787C Patient Care 5
41. The binding of DHT to the androgen receptor is generally ____ than the binding of testosterone.
- a. weaker
- b. stronger and more stable
- c. identical
- d. slower
Answer: b. stronger and more stable
42. Which functional group is common to both testosterone and estradiol?
- a. A C3-keto group
- b. A C17-hydroxyl group
- c. An aromatic A-ring
- d. A C19-methyl group
Answer: b. A C17-hydroxyl group
43. A key skill for a pharmacist is to recognize drug classes based on:
- a. The color of the tablet.
- b. The cost of the medication.
- c. Common suffixes in the drug name (e.g., “-steride”).
- d. The marketing campaign.
Answer: c. Common suffixes in the drug name (e.g., “-steride”).
44. The development of non-steroidal molecules that can fit into the steroid receptor pocket is an example of:
- a. Rational drug design.
- b. A failed clinical trial.
- c. A prodrug strategy.
- d. An accident.
Answer: a. Rational drug design.
45. Which of the following is NOT an androgen?
- a. Testosterone
- b. Dihydrotestosterone
- c. Androstenedione
- d. Progesterone
Answer: d. Progesterone
46. The study of how a drug’s structure influences its ADME properties is a central theme of medicinal chemistry.
- a. True
- b. False
Answer: a. True
47. The “Hormonal Agents” lecture for oncology is part of the Patient Care 2 curriculum.
- a. True
- b. False
Answer: a. True
48. An active learning session on men’s health is part of which course module?
- a. Module 8: Urological Disorders
- b. Module 1: Diabetes Mellitus
- c. Module 4: Medication Safety
- d. Module 6: Geriatrics
Answer: a. Module 8: Urological Disorders
49. The overall goal of designing androgen therapies is to:
- a. Create the most potent molecule possible, regardless of side effects.
- b. Create molecules with desirable pharmacokinetic profiles and receptor interactions to treat specific medical conditions.
- c. Make drugs that are difficult to synthesize.
- d. Only create oral formulations.
Answer: b. Create molecules with desirable pharmacokinetic profiles and receptor interactions to treat specific medical conditions.
50. The ultimate reason to learn the medicinal chemistry of androgens is to:
- a. Understand the “why” behind their pharmacology, which leads to safer and more effective use in patients.
- b. Be able to draw testosterone from memory.
- c. Pass the medicinal chemistry exam.
- d. Appreciate the complexity of steroid synthesis.
Answer: a. Understand the “why” behind their pharmacology, which leads to safer and more effective use in patients.
